High-dose intravenous anakinra treatment is safe and effective in severe and critical COVID-19 patients: a propensity score-matched study in a single center
Article in Inflammopharmacology (January 2023)
The most recent citing publications are shown below. View all 46 publications that cite this research output on Dimensions.
High Dose Intravenous Anakinra Treatment is Safe and Effective in Severe and Critical COVID-19 Patients: A Propensity Score Matched Study in a Single Center
Preprint in Research Square (January 2023)
Diagnosis and treatment of adult-onset Still’s disease: a concise summary of the German society of rheumatology S2 guideline
Article in Zeitschrift für Rheumatologie (December 2022)